Key statistics
On Tuesday, AbbVie Inc (ABBVCL:SGO) closed at 172,200.00, -4.66% below its 52-week high of 180,620.00, set on Aug 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 172,200.00 |
---|---|
High | 172,200.00 |
Low | 172,200.00 |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | 10.00 |
---|---|
Shares outstanding | 1.77bn |
Free float | 1.77bn |
P/E (TTM) | 59.91 |
Market cap | 303.47bn USD |
EPS (TTM) | 2.87 USD |
Annual div (ADY) | 6,388.98 CLP |
---|---|
Annual div yield (ADY) | 3.71% |
Div ex-date | Oct 15 2024 |
Div pay-date | Nov 15 2024 |
Next div ex-date | Jan 15 2025 |
Next div pay-date | Feb 14 2025 |
Data delayed at least 20 minutes, as of Nov 12 2024 16:32 GMT.
More ▼
Press releases
- PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
- Seaport Therapeutics Names Lauren White as Chief Financial Officer
- NImmune Biopharma Announces R&D Collaboration with BioTherapeutics, Inc. to Advance the Next Wave of Inflammation and Immunology Precision Medicines